Provision of WES Trio and Singleton Virtual Panel Analysis for Welsh Patients
Estimated value
—
Awarded value
—
Suppliers
1
Lots
1
Published
24 Jun 2021
Description
In-line with All Wales Medical Genomic Service’s (AWMGS) commissioning model, AWMGS will procure from CeGaT whole exom sequencing (WES) for trio or singleton virtual panel analysis for patients where this testing cannot be accessed within the NHS E laboratory network. This genetic testing will ensure equity of access to genomic testing for Welsh patients and meet their need to seek a timely genetic diagnosis for their rare or inherited disease.
Scope
- Reference
- CAV-STA (2021/2022) 11
- Commercial tool
- Standalone contract
- Main category
- services
- Contract locations
- Wales
Submission & procedure
- Procedure
- Award procedure without prior publication of a call for competition
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
—
Award date
—
Contract start
—
Contract end
—
Awarded suppliers· 1 supplier
Awarded —
Other contracts from NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
Full notice and award history for this contracting authority is on the buyer profile.
Other contracts awarded to CeGaT GmbH· 4
Cross-buyer view of this supplier's public-sector wins.
| Title | Type | Value | Published |
|---|---|---|---|
| UK Research and Innovation - Oligonucleotide Synthesis and Nucleic Acid Sequencing Services Framework | contract | — | 25 Jun 2024 |
| Purchase of Rare or Inherited Disease Test Directory testing for Welsh patients | contract | — | 15 May 2024 |
| EC0900 Lot 1 - Short Read Genomic Sequencing | contract | — | 14 Jul 2022 |
| CEFAS22-11 Next Generation Sequencing (NGS Framework) | contract | — | 27 Jun 2022 |